Carlos Orantes

AMPLIFY Clinical, Inc. operates as a clinical research site. It owns Meridian Research, Insearch Site Network and NeuroStudies. The company is headquartered in Winter Park, FL.

hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn.

AMPLIFY Clinical, Inc. operates as a clinical research site. It owns Meridian Research, Insearch Site Network and NeuroStudies. The company is headquartered in Winter Park, FL.

hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn.

hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn.